2011年1月27日 · The major side effect associated with cetuximab treatment is skin toxicity, including skin rash, dry skin, hair growth disorders, pruritus, and nail changes [15, 16]. …

2013年5月15日 · The acneiform rash is characterized by erythematous papules and pustules that develop on the face, scalp, and upper trunk within the first month in > 90% of patients. Not …

Rash occurred on 90% of patients treated with cetuximab monotherapy and grade 3 or 4 skin reactions occurred on as many as 16% of patients in the trials using cetuximab. A rash usually …

88% of patients who received cetuximab developed a rash, 17% of which were at least grade 3. The pharma recommen - dations for managing the drug rash include a drug delay for up to 2 …

2020年4月21日 · The major side effect associated with cetuximab treat- ment is skin toxicity, including skin rash, dry skin, hair growth disorders, pruritus, and nail changes [15, 16].

2014年1月22日 · Patients who develop skin reactions to cetuximab and erlotinib generally have a higher response to treatment and an increased survival rate. 10,12-14 This positive correlation …

Present study evaluated the severity of cetuximab-induced skin rash and its correlation with clinical outcome and late skin toxicity in patients HNSCC treated with chemoradiotherapy and …

Preemptive therapy of cetuximab-induced skin rash using doxycycline, sunscreen, hydrocortisone, and moisturizer in colorectal and head and neck cancer patients.

933 cetuximab-treated patients enrolled on N0147, an adjuvant chemotherapy trial for colon cancer, were evaluated for clinical risk factors of severe rash. Within this cohort, 50 patients …

2023年5月1日 · Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor with the following FDA-approved indications: colorectal cancer, metastatic, KRAS wild-type (without …